$260 million funding injection for Danish vaccines initiative
The Novo Nordisk Foundation is investing up to $260 million in a vaccines research and development initiative focused on respiratory diseases.
List view / Grid view
The Novo Nordisk Foundation is investing up to $260 million in a vaccines research and development initiative focused on respiratory diseases.
A first-of-its-kind experimental chlamydia vaccine trial has been found to be safe and able to provoke an immune response.